ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 171 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2019. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $585,100 | -19.9% | 14,236 | -9.0% | 0.00% | 0.0% |
| Q1 2024 | $730,372 | -22.0% | 15,643 | -20.1% | 0.00% | -50.0% |
| Q4 2023 | $936,220 | +18.8% | 19,578 | -11.4% | 0.00% | +100.0% |
| Q3 2023 | $788,150 | +76.0% | 22,108 | +127.8% | 0.00% | 0.0% |
| Q2 2023 | $447,692 | +120.5% | 9,705 | +231.3% | 0.00% | 0.0% |
| Q1 2019 | $203,000 | -65.7% | 2,929 | -64.9% | 0.00% | -80.0% |
| Q3 2016 | $592,000 | – | 8,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
| Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
| Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
| AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
| EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
| FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
| HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
| Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |